Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer

Infinity Pharmaceuticals, Inc. · 2011
ClinicalTrials.gov · Datasets · License: Public Domain · 2011
Open Source ↗
nsclcsmallcelllungcancer
non-small cell lung cancer, kras mutant, nsclc, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 913528
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.